Literature DB >> 11921747

Nongranulomatous anterior uveitis associated with alendronate therapy.

Siham Salmen1, Lisbeth Berrueta, Nelly Sánchez, Henry Montes, Lérida Borges.   

Abstract

We describe a case of acute nongranulomatous anterior uveitis associated with alendronate therapy, in an adult woman, without medical history of previous diseases, except for intercurrent problems of osteoporosis. The symptoms disappeared abruptly after anti-inflammatory therapy and discontinuation of alendronate. Side effects associated with ocular inflammation have been recently documented in 3 patients under alendronate therapy. Clinical and laboratory diagnosis of ocular inflammation syndromes are also reviewed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11921747

Source DB:  PubMed          Journal:  Invest Clin        ISSN: 0535-5133            Impact factor:   0.683


  5 in total

1.  Prescription-event monitoring study on 13,164 patients prescribed risedronate in primary care in England.

Authors:  Beate Aurich Barrera; Lynda Wilton; Scott Harris; Saad A W Shakir
Journal:  Osteoporos Int       Date:  2005-08-31       Impact factor: 4.507

2.  Ophthalmological events in patients receiving risedronate: summary of information gained through follow-up in a prescription-event monitoring study in England.

Authors:  Beate Aurich-Barrera; Lynda Wilton; Scott Harris; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

3.  A case report: zoledronic acid-induced anterior uveitis.

Authors:  Saadettin Kilickap; Yasemin Ozdamar; M Kadri Altundag; Omer Dizdar
Journal:  Med Oncol       Date:  2007-09-08       Impact factor: 3.064

4.  Unilateral anterior uveitis complicating zoledronic acid therapy in breast cancer.

Authors:  Nagi S El Saghir; Zaher K Otrock; Jamal H Bleik
Journal:  BMC Cancer       Date:  2005-12-06       Impact factor: 4.430

5.  Drug-induced uveitis.

Authors:  Nikolas Js London; Sunir J Garg; Ramana S Moorthy; Emmett T Cunningham
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-03-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.